Table of Contents

2019-2024 Global Diagnostic Nuclear Medicines Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Nuclear Medicines Consumption 2014-2024
2.1.2 Diagnostic Nuclear Medicines Consumption CAGR by Region
2.2 Diagnostic Nuclear Medicines Segment by Type
2.2.1 Tc-99m
2.2.2 F-18
2.2.3 Other
2.3 Diagnostic Nuclear Medicines Consumption by Type
2.3.1 Global Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
2.3.2 Global Diagnostic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
2.3.3 Global Diagnostic Nuclear Medicines Sale Price by Type (2014-2019)
2.4 Diagnostic Nuclear Medicines Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Nuclear Medicines Consumption by Application
2.5.1 Global Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
2.5.2 Global Diagnostic Nuclear Medicines Value and Market Share by Application (2014-2019)
2.5.3 Global Diagnostic Nuclear Medicines Sale Price by Application (2014-2019)

3 Global Diagnostic Nuclear Medicines by Players
3.1 Global Diagnostic Nuclear Medicines Sales Market Share by Players
3.1.1 Global Diagnostic Nuclear Medicines Sales by Players (2017-2019)
3.1.2 Global Diagnostic Nuclear Medicines Sales Market Share by Players (2017-2019)
3.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Players
3.2.1 Global Diagnostic Nuclear Medicines Revenue by Players (2017-2019)
3.2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Players (2017-2019)
3.3 Global Diagnostic Nuclear Medicines Sale Price by Players
3.4 Global Diagnostic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Diagnostic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Diagnostic Nuclear Medicines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Diagnostic Nuclear Medicines by Regions
4.1 Diagnostic Nuclear Medicines by Regions
4.1.1 Global Diagnostic Nuclear Medicines Consumption by Regions
4.1.2 Global Diagnostic Nuclear Medicines Value by Regions
4.2 Americas Diagnostic Nuclear Medicines Consumption Growth
4.3 APAC Diagnostic Nuclear Medicines Consumption Growth
4.4 Europe Diagnostic Nuclear Medicines Consumption Growth
4.5 Middle East & Africa Diagnostic Nuclear Medicines Consumption Growth

5 Americas
5.1 Americas Diagnostic Nuclear Medicines Consumption by Countries
5.1.1 Americas Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
5.1.2 Americas Diagnostic Nuclear Medicines Value by Countries (2014-2019)
5.2 Americas Diagnostic Nuclear Medicines Consumption by Type
5.3 Americas Diagnostic Nuclear Medicines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Diagnostic Nuclear Medicines Consumption by Countries
6.1.1 APAC Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
6.1.2 APAC Diagnostic Nuclear Medicines Value by Countries (2014-2019)
6.2 APAC Diagnostic Nuclear Medicines Consumption by Type
6.3 APAC Diagnostic Nuclear Medicines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Diagnostic Nuclear Medicines by Countries
7.1.1 Europe Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
7.1.2 Europe Diagnostic Nuclear Medicines Value by Countries (2014-2019)
7.2 Europe Diagnostic Nuclear Medicines Consumption by Type
7.3 Europe Diagnostic Nuclear Medicines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Nuclear Medicines by Countries
8.1.1 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Diagnostic Nuclear Medicines Value by Countries (2014-2019)
8.2 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Type
8.3 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Diagnostic Nuclear Medicines Distributors
10.3 Diagnostic Nuclear Medicines Customer

11 Global Diagnostic Nuclear Medicines Market Forecast
11.1 Global Diagnostic Nuclear Medicines Consumption Forecast (2019-2024)
11.2 Global Diagnostic Nuclear Medicines Forecast by Regions
11.2.1 Global Diagnostic Nuclear Medicines Forecast by Regions (2019-2024)
11.2.2 Global Diagnostic Nuclear Medicines Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Diagnostic Nuclear Medicines Forecast by Type
11.8 Global Diagnostic Nuclear Medicines Forecast by Application

12 Key Players Analysis
12.1 Bracco Imaging
12.1.1 Company Details
12.1.2 Diagnostic Nuclear Medicines Product Offered
12.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bracco Imaging News
12.2 Bayer
12.2.1 Company Details
12.2.2 Diagnostic Nuclear Medicines Product Offered
12.2.3 Bayer Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Bayer News
12.3 Curium Pharmaceuticals
12.3.1 Company Details
12.3.2 Diagnostic Nuclear Medicines Product Offered
12.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Curium Pharmaceuticals News
12.4 Nordion
12.4.1 Company Details
12.4.2 Diagnostic Nuclear Medicines Product Offered
12.4.3 Nordion Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Nordion News
12.5 Triad Isotopes
12.5.1 Company Details
12.5.2 Diagnostic Nuclear Medicines Product Offered
12.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Triad Isotopes News
12.6 Lantheus
12.6.1 Company Details
12.6.2 Diagnostic Nuclear Medicines Product Offered
12.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Lantheus News
12.7 GE Healthcare
12.7.1 Company Details
12.7.2 Diagnostic Nuclear Medicines Product Offered
12.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 GE Healthcare News
12.8 China Isotope & Radiation
12.8.1 Company Details
12.8.2 Diagnostic Nuclear Medicines Product Offered
12.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 China Isotope & Radiation News
12.9 Jubilant Pharma
12.9.1 Company Details
12.9.2 Diagnostic Nuclear Medicines Product Offered
12.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Jubilant Pharma News
12.10 Eli Lilly
12.10.1 Company Details
12.10.2 Diagnostic Nuclear Medicines Product Offered
12.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Eli Lilly News
12.11 Novartis
12.12 SIEMENS
12.13 Dongcheng
12.14 Navidea

13 Research Findings and Conclusion